주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Committee & Speakers

Conference Chairs

Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany

Fen-Biao Gao, University of Massachusetts, USA

Aaron Gitler, University of Stanford, USA

Speakers

Keynote Victor Ambros, University of Massachusetts Chan Medical School, USA

Session 1: Dysregulated RNA metabolism in neurological diseases Pietro Fratta, University of College London, UK Leslie Thompson, University of California, Irvine, USA

Session 2: Physiological functions of disease-linked RNA-binding proteins Joel Richter, University of Massachusetts Chan Medical School, USA Gene Yeo, University of California, San Diego, USA

Session 3: Biomolecular condensates and their role in normal RNA processing and in disease Simon Alberti, Dresden University of Technology, Germany Roy Parker, University of Colorado, Boulder, USA

Session 4: Human genetics and genomics insights into neurological diseases Don Cleveland, University of California, San Diego, USA Rosa Rademakers, VIB Center for Molecular Neurology, Antwerp, Belgium

Session 5: Structural insights into pathological RNA-binding proteins Magdalini Polymenidou, University of Zürich, Switzerland Ben Ryskeldi-Falcon, MRC Cambridge, UK

Session 6: Toxicity of repeat RNAs and repeat proteins Dieter Edbauer, German Center for Neurodegenerative Diseases, Munich, Germany Laura Ranum, University of Florida, USA

Session 7: Novel biomarkers due to dysregulated RNA metabolism Michael Ward, National Institutes of Health, USA Philip Wong, The John Hopkins University, USA

Session 8: RNA-based therapeutics Anastasia Khvorova, University of Massachusetts Chan Medical School, USA Matthew Simon, Denali Therapeutics, USA